413 related articles for article (PubMed ID: 17611870)
1. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
2. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
3. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S
Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
[TBL] [Abstract][Full Text] [Related]
10. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of
Wang J; Zhang R
Br J Radiol; 2017 Mar; 90(1071):20160836. PubMed ID: 28106465
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone-induced thyrotoxicosis: a review.
Tsang W; Houlden RL
Can J Cardiol; 2009 Jul; 25(7):421-4. PubMed ID: 19584973
[TBL] [Abstract][Full Text] [Related]
14. Color flow Doppler sonography in thyrotoxicosis factitia.
Bogazzi F; Bartalena L; Vitti P; Rago T; Brogioni S; Martino E
J Endocrinol Invest; 1996 Oct; 19(9):603-6. PubMed ID: 8957744
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
O'Sullivan AJ; Lewis M; Diamond T
Eur J Endocrinol; 2006 Apr; 154(4):533-6. PubMed ID: 16556715
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
Alyan O; Arda K; Ozdemir O; Acu B; Soylu M; Demirkan D
Med Sci Monit; 2003 Sep; 9(9):PI117-22. PubMed ID: 12960935
[TBL] [Abstract][Full Text] [Related]
19. [Amiodarone treatment and thyroid disorders].
Łacka K; Fraczek MM
Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
